MiMedx Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6024961012
USD
5.26
-0.16 (-2.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
113.72
98.61
88.20
92.91
84.06
87.21
84.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
113.72
98.61
88.20
92.91
84.06
87.21
84.71
Raw Material Cost
18.83
18.78
16.66
17.10
15.51
15.04
13.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.42
0.47
0.00
2.53
0.00
0.00
1.69
Selling and Distribution Expenses
69.00
64.15
59.97
61.04
53.52
55.40
55.13
Other Expenses
0.33
0.28
0.33
0.10
0.29
0.30
0.12
Total Expenditure (Excl Depreciation)
91.53
86.23
79.95
81.72
71.95
73.46
71.15
Operating Profit (PBDIT) excl Other Income
22.200000000000003
12.4
8.299999999999999
11.200000000000001
12.1
13.700000000000001
13.600000000000001
Other Income
1.08
1.11
0.36
2.72
0.26
-0.23
-0.10
Operating Profit (PBDIT)
28.56
16.65
11.81
14.63
12.49
23.98
13.90
Interest
0.42
0.47
0.00
2.53
0.00
0.00
1.69
Exceptional Items
0.00
0.00
0.00
-0.09
-0.30
0.00
-0.05
Gross Profit (PBDT)
94.89
79.82
71.55
75.81
68.54
72.16
71.53
Depreciation
5.29
3.16
3.20
0.76
0.77
0.77
0.75
Profit Before Tax
22.85
13.01
8.61
11.25
11.42
23.22
11.41
Tax
6.10
3.39
1.59
3.81
3.54
5.59
2.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.75
9.62
7.02
7.44
7.88
17.62
9.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.75
9.62
7.02
7.44
7.88
17.62
9.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.75
9.62
7.02
7.44
7.88
17.62
9.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
238.95
216.62
202.78
193.11
181.01
168.04
155.73
Earnings per share (EPS)
0.11
0.06
0.05
0.05
0.05
0.12
0.06
Diluted Earnings per share
0.11
0.06
0.05
0.05
0.05
0.12
0.06
Operating Profit Margin (Excl OI)
19.51%
12.55%
9.35%
12.0%
13.63%
26.89%
15.64%
Gross Profit Margin
24.74%
16.4%
13.39%
12.92%
14.5%
27.5%
14.35%
PAT Margin
14.73%
9.75%
7.96%
8.01%
9.37%
20.21%
10.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 15.31% vs 11.79% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 73.96% vs 37.14% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 77.42% vs 34.78% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -20.00% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of MiMedx Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
113.72
175.00
-61.28
-35.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
113.72
175.00
-61.28
-35.02%
Raw Material Cost
18.83
82.90
-64.07
-77.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.42
2.00
-1.58
-79.00%
Selling and Distribution Expenses
69.00
79.00
-10.00
-12.66%
Other Expenses
0.33
0.38
-0.05
-13.16%
Total Expenditure (Excl Depreciation)
91.53
167.70
-76.17
-45.42%
Operating Profit (PBDIT) excl Other Income
22.19
7.30
14.89
203.97%
Other Income
1.08
0.30
0.78
260.00%
Operating Profit (PBDIT)
28.56
17.60
10.96
62.27%
Interest
0.42
2.00
-1.58
-79.00%
Exceptional Items
0.00
-81.50
81.50
100.00%
Gross Profit (PBDT)
94.89
92.10
2.79
3.03%
Depreciation
5.29
10.00
-4.71
-47.10%
Profit Before Tax
22.85
-75.90
98.75
130.11%
Tax
6.10
0.90
5.20
577.78%
Provisions and contingencies
0
0
0.00
Profit After Tax
16.75
-76.80
93.55
121.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
16.75
-76.80
93.55
121.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.75
-76.80
93.55
121.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
238.95
776.30
-537.35
-69.22%
Earnings per share (EPS)
0.11
-1.66
1.77
106.63%
Diluted Earnings per share
0.11
-1.66
1.77
106.63%
Operating Profit Margin (Excl OI)
19.51%
4.17%
0.00
15.34%
Gross Profit Margin
24.74%
-37.66%
0.00
62.40%
PAT Margin
14.73%
-43.89%
0.00
58.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.37 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 15.31% vs 11.79% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 35.20% vs 2.94% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.67 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 73.96% vs 37.14% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 111.39% vs -10.23% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.75 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 77.42% vs 34.78% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 125.41% vs 1.67% in Sep 2024

Quarterly - Interest
Interest 0.04 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -20.00% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.51%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024